Reaction Details Report a problem with these data
Target
Plasma kallikrein
Ligand
BDBM50032865
Substrate
n/a
Meas. Tech.
ChEMBL_1443466 (CHEMBL3377180)
Ki
940±n/a nM
Citation
 Hangeland, JJ; Friends, TJ; Rossi, KA; Smallheer, JM; Wang, C; Sun, Z; Corte, JR; Fang, T; Wong, PC; Rendina, AR; Barbera, FA; Bozarth, JM; Luettgen, JM; Watson, CA; Zhang, G; Wei, A; Ramamurthy, V; Morin, PE; Bisacchi, GS; Subramaniam, S; Arunachalam, P; Mathur, A; Seiffert, DA; Wexler, RR; Quan, ML Phenylimidazoles as potent and selective inhibitors of coagulation factor XIa with in vivo antithrombotic activity. J Med Chem 57:9915-32 (2014) [PubMed]  Article 
Target
Name:
Plasma kallikrein
Synonyms:
Fletcher factor | KLK3 | KLKB1 | KLKB1_HUMAN | Kallikrein | Kininogenin | Plasma kallikrein heavy chain | Plasma kallikrein light chain | Plasma prekallikrein
Type:
Protein
Mol. Mass.:
71391.16
Organism:
Homo sapiens (Human)
Description:
P03952
Residue:
638
Sequence:
MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA
  
Inhibitor
Name:
BDBM50032865
Synonyms:
CHEMBL3355665
Type:
Small organic molecule
Emp. Form.:
C28H30F3N5O3
Mol. Mass.:
541.5647
SMILES:
OC(=O)C(F)(F)F.NC[C@H]1CC[C@@H](CC1)C(=O)N[C@@H](Cc1ccccc1)c1nc(c[nH]1)-c1ccc(cc1)C#N |r,wU:18.18,12.14,wD:9.7,(25.97,-5.14,;27.3,-5.91,;27.3,-7.45,;28.64,-5.14,;29.97,-5.91,;29.96,-4.35,;28.64,-3.6,;10.28,-12.71,;11.61,-13.48,;12.94,-12.72,;14.28,-13.49,;15.62,-12.73,;15.62,-11.18,;14.29,-10.41,;12.95,-11.18,;16.95,-10.41,;16.95,-8.87,;18.28,-11.18,;19.62,-10.41,;19.62,-8.87,;20.96,-8.1,;22.29,-8.88,;23.62,-8.11,;23.62,-6.57,;22.28,-5.8,;20.95,-6.57,;20.95,-11.18,;22.36,-10.56,;23.39,-11.7,;22.62,-13.04,;21.11,-12.71,;24.92,-11.54,;25.54,-10.13,;27.06,-9.97,;27.98,-11.22,;27.35,-12.63,;25.82,-12.79,;29.5,-11.05,;31.03,-10.89,)|
Structure:
Search PDB for entries with ligand similarity: